サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1501636

欧州の合成ホルモン市場：製品タイプ・投与経路・用途・エンドユーザー・国別の分析・予測 (2023-2033年)

Europe Synthetic Hormones Market: Focus on Product Type, Route of Administration, Application, End User, and Country - Analysis and Forecast, 2023-2033

出版日
発行
BIS Research
ページ情報
英文 67 Pages
納期
1～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
欧州の合成ホルモン市場：製品タイプ・投与経路・用途・エンドユーザー・国別の分析・予測 (2023-2033年)
出版日: 2024年06月27日
発行: BIS Research
ページ情報: 英文 67 Pages
納期: 1～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の合成ホルモンの市場規模は、2023年の49億米ドルから、予測期間中は7.94％のCAGRで推移し、2033年には105億3,000万米ドルの規模に成長すると予測されています。

合成ホルモン市場は、参入事業者による革新的な合成ホルモンの開発により発展しています。

主要市場統計
予測期間 2023-2033年
2023年評価 49億米ドル
2033年予測 105億3,000万米ドル
CAGR 7.94%

欧州の合成ホルモンの市場は、治療法や治療薬の進化を目指した活発なR&D活動が特徴です。同地域の主要な製薬会社は、さまざまな病状に対処するための革新的な合成ホルモンの開発と製品化に積極的に取り組んでいます。この市場を牽引しているのは、医療費の増加、甲状腺機能障害やホルモン関連の癌などのホルモン疾患の有病率の上昇、高度な治療オプションに関する医療の専門家や患者の意識の高まりです。規制当局の支援と厳格な品質基準も、合成ホルモン製品の安全性と有効性を保証することにより、市場の成長をさらに後押しします。バイオテクノロジーと製薬科学における継続的な進歩により、欧州は最先端の合成ホルモン療法を開発・採用する重要な拠点であり続け、大陸全体の患者転帰の改善とヘルスケアの進歩に貢献しています。

市場セグメンテーション

セグメント1：製品タイプ別

  • ステロイドホルモン
  • ペプチドホルモン
  • その他

セグメント2：投与経路別

  • 皮下
  • 経口
  • 静脈内/筋肉内
  • その他

セグメント3：用途別

  • 糖尿病
  • 成長ホルモン欠乏症
  • 避妊
  • 男性性腺機能低下症
  • 更年期障害
  • その他

セグメント4：エンドユーザー別

  • 病院薬局
  • 小売薬局
  • オンライン薬局

セグメント5：国別

  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • その他

当レポートでは、欧州の合成ホルモンの市場を調査し、業界の動向、技術・特許の動向、法規制環境、市場成長促進要因・抑制要因、市場規模の推移・予測、各種区分・主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

エグゼクティブサマリー

第1章 市場

  • 動向：現在および将来の影響評価
    • トレンド1：パーソナライズされた合成ホルモン療法
    • トレンド2：AIの統合
  • 市場規模と成長の可能性
  • R&Dレビュー
    • 特許公開動向（国別）
    • 特許公開動向（年別）
  • 規制状況
  • 市場力学：概要
    • 市場促進要因
    • 市場抑制要因
    • 市場機会

第2章 地域

  • 地域別概要
  • 促進要因・抑制要因
  • 欧州
    • 市場成長推進因子
    • 市場課題
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • その他

第3章 市場：競合ベンチマーキング・企業プロファイル

  • 企業評価
    • Ferring B.V.
    • Novo Nordisk A/S
    • Ipsen Pharma
    • Novartis AG
    • Perrigo Company plc
    • Sanofi

第4章 調査手法

図表

List of Figures

  • Figure 1: Europe Synthetic Hormones Optimistic, Pessimistic and Realistic Growth, 2023, 2027,2033
  • Figure 2: Synthetic Hormones Market (by Region), $Billion, 2022, 2027, and 2033
  • Figure 3: Europe Synthetic Hormones Market (by Product Type), $Billion, 2022, 2027, and 2033
  • Figure 4: Europe Synthetic Hormones Market (by Route of Administration), $Billion, 2022, 2027, and 2033
  • Figure 5: Key Events to Keep Track of within Synthetic Hormones Market
  • Figure 6: Benefits of Personalized Synthetic Hormone Therapies
  • Figure 7: AI Utilization in Synthetic Hormones
  • Figure 8: Europe Synthetic Hormones Market, $Billion, 2022-2033
  • Figure 9: Patent Published (by Country), January 2020-December 2023
  • Figure 10: Patent Published (by Year), January 2020-December 2023
  • Figure 11: Impact Analysis of Market Dynamics, 2022-2033
  • Figure 12: Trends in Occurrence of Diabetes, 2001-2020
  • Figure 13: Hormonal Disorders and their Prevalence Globally, 2020
  • Figure 14: Uptake of HRT Medicines and Prescribing Rate, Europe
  • Figure 15: Examples of a Few Technological Advancements
  • Figure 16: Factors Contributing to High Developmental Costs
  • Figure 17: Cost of Synthetic Hormone Therapy
  • Figure 18: Regulatory Process for Synthetic Hormones
  • Figure 19: Indications and Applications of Synthetic Hormones
  • Figure 20: Factors Contributing to Precision Medicine for Synthetic Hormones
  • Figure 21: Strategic Initiatives, 2021-2023
  • Figure 22: Data Triangulation
  • Figure 23: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Synthetic Hormones Market (by Region), $Billion, 2022-2033
  • Table 4: Europe Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 5: Europe Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 6: Europe Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 7: Europe Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 8: U.K. Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 9: U.K. Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 10: U.K. Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 11: U.K. Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 12: Germany Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 13: Germany Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 14: Germany Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 15: Germany Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 16: France Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 17: France Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 18: France Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 19: France Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 20: Italy Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 21: Italy Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 22: Italy Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 23: Italy Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 24: Spain Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 25: Spain Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 26: Spain Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 27: Spain Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 28: Rest-of-Europe Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 29: Rest-of-Europe Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 30: Rest-of-Europe Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 31: Rest-of-Europe Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 32: Market Share
目次
Product Code: BHL2158SS

Introduction to Europe Synthetic Hormones Market

The Europe synthetic hormones market size was estimated at $4.90 billion in 2023 and is expected to reach $10.53 billion by 2033, growing at a CAGR of 7.94% during the forecast period 2023-2033. The synthetic hormones market is advancing due to significant developments anticipated from key market players focused on creating innovative synthetic hormones.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$4.90 Billion
2033 Forecast$10.53 Billion
CAGR7.94%

Market Introduction

The Europe synthetic hormones market is characterized by robust research and development activities aimed at advancing medical treatments and therapies. Key pharmaceutical companies across the region are actively engaged in developing and commercializing innovative synthetic hormones to address various medical conditions. This market is driven by increasing healthcare expenditure, rising prevalence of hormonal disorders such as thyroid dysfunction and hormone-related cancers, and growing awareness among healthcare professionals and patients about advanced treatment options. Regulatory support and stringent quality standards further bolster market growth by ensuring the safety and efficacy of synthetic hormone products. With ongoing advancements in biotechnology and pharmaceutical sciences, Europe continues to be a significant hub for the development and adoption of cutting-edge synthetic hormone therapies, contributing to improved patient outcomes and healthcare advancements across the continent.

Market Segmentation:

Segmentation 1: by Product Type

  • Steroid Hormones
  • Peptide Hormones
  • Others

Segmentation 2: by Route of Administration

  • Subcutaneous
  • Oral
  • Intravenous/Intramuscular
  • Others

Segmentation 3: by Application

  • Diabetes
  • Growth Hormone Deficiency
  • Contraception
  • Male Hypogonadism
  • Menopause
  • Others

Segmentation 4: by End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Segmentation 5: by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The Europe synthetic hormones market (by product type) has been segmented based on product type, including peptide hormones, steroid hormones, and others. Moreover, the study provides the reader with a detailed understanding of the different routes of administration and application.

Growth/Marketing Strategy: To foster growth in the synthetic hormones market, a dual strategy focusing on research and development for safer, more effective formulations, alongside expanding outreach through strategic partnerships and education campaigns, is essential. Emphasizing personalized medicine and leveraging digital platforms for market expansion and patient engagement can also be pivotal in driving market growth and visibility.

Competitive Strategy: Key players in the Europe synthetic hormones market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the synthetic hormones market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names in the market include:

  • Ferring B.V.
  • Novo Nordisk A/S
  • Ipsen Pharma
  • Novartis AG
  • Perrigo Company plc
  • Sanofi

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Trend 1: Personalized Synthetic Hormones Therapies
    • 1.1.2 Trend 2: Integration of Artificial Intelligence (AI)
  • 1.2 Market Footprint and Growth Potential, $Billion, 2022-2033
  • 1.3 Research and Development Review
    • 1.3.1 Patent Publishing Trend (by Country)
    • 1.3.2 Patent Publishing Trend (by Year)
  • 1.4 Regulatory Landscape
  • 1.5 Market Dynamics: Overview
    • 1.5.1 Market Drivers
    • 1.5.2 Market Restraints
    • 1.5.3 Market Opportunities

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Driving Factors for Market Growth
    • 2.3.2 Factors Challenging the Market
    • 2.3.3 U.K.
    • 2.3.4 Germany
    • 2.3.5 France
    • 2.3.6 Italy
    • 2.3.7 Spain
    • 2.3.8 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Company Assessment
    • 3.1.1 Ferring B.V.
      • 3.1.1.1 Overview
      • 3.1.1.2 Top Products
      • 3.1.1.3 Top Competitors
      • 3.1.1.4 Key Personnel
      • 3.1.1.5 Analyst View
    • 3.1.2 Novo Nordisk A/S
      • 3.1.2.1 Overview
      • 3.1.2.2 Top Products
      • 3.1.2.3 Top Competitors
      • 3.1.2.4 Key Personnel
      • 3.1.2.5 Analyst View
    • 3.1.3 Ipsen Pharma
      • 3.1.3.1 Overview
      • 3.1.3.2 Top Products
      • 3.1.3.3 Top Competitors
      • 3.1.3.4 Key Personnel
      • 3.1.3.5 Analyst View
    • 3.1.4 Novartis AG
      • 3.1.4.1 Overview
      • 3.1.4.2 Top Products
      • 3.1.4.3 Top Competitors
      • 3.1.4.4 Key Personnel
      • 3.1.4.5 Analyst View
    • 3.1.5 Perrigo Company plc
      • 3.1.5.1 Overview
      • 3.1.5.2 Top Products
      • 3.1.5.3 Top Competitors
      • 3.1.5.4 Key Personnel
      • 3.1.5.5 Analyst View
    • 3.1.6 Sanofi
      • 3.1.6.1 Overview
      • 3.1.6.2 Top Products
      • 3.1.6.3 Top Competitors
      • 3.1.6.4 Key Personnel
      • 3.1.6.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation